Skip to main content

ADVERTISEMENT

Michele Impreveduto, RN, BA, MPA, RNC

04/04/2013
Under the FDA-approved expanded use protocol, the Structural Heart Team at Lenox Hill Heart and Vascular Institute-NSLIJ Health System has successfully implanted the first CoreValve inside a degenerative aortic bioprosthesis (ViV) in the U.S.
Under the FDA-approved expanded use protocol, the Structural Heart Team at Lenox Hill Heart and Vascular Institute-NSLIJ Health System has successfully implanted the first CoreValve inside a degenerative aortic bioprosthesis (ViV) in the U.S.
Under the FDA-approved expanded...
04/04/2013
Cath Lab Digest
07/30/2008
A female patient was diagnosed with triple-vessel disease, requiring coronary artery bypass surgery in 1985. After a 10-day length of stay, she was discharged to home and started on a regimen of cardiac medications. Within months, a complete...
A female patient was diagnosed with triple-vessel disease, requiring coronary artery bypass surgery in 1985. After a 10-day length of stay, she was discharged to home and started on a regimen of cardiac medications. Within months, a complete...
A female patient was diagnosed...
07/30/2008
Cath Lab Digest
Feature
07/30/2008
A female patient was diagnosed with triple-vessel disease, requiring coronary artery bypass surgery in 1985. After a 10-day length of stay, she was discharged to home and started on a regimen of cardiac medications. Within months, a complete...
A female patient was diagnosed with triple-vessel disease, requiring coronary artery bypass surgery in 1985. After a 10-day length of stay, she was discharged to home and started on a regimen of cardiac medications. Within months, a complete...
A female patient was diagnosed...
07/30/2008
Cath Lab Digest